Skip to content

Clinical trials

Observational Hypoparathyroidism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Phase: Observational Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20131
20151
20222
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma A/S2
Bettina Mittendorfer1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Columbia University1
McLennan County Medical Education and Research Foundation1
National Institute of Dental and Craniofacial Research (NIDCR)1
Shire1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism9
Bone Diseases, Metabolic2
Hyperparathyroidism2
Osteoporosis2
Cachexia1
Calcium Metabolism Disorders1
Cystic Fibrosis1
Diabetes Mellitus1
Heart Failure1
Hypercalciuria1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.